13 May 2016 - A drug that saved Ron Walker from melanoma may also be able to save patients from 30 other types of cancer.

Immunotherapy drug Keytruda is now showing promising results in 250 international trials, offering hope of a new treatment to thousands of desperate Australians with cancers ranging from breast, pancreatic and lung tumours, to those with leukaemia, myeloma and lymphomas.

Researchers have discovered that the same biomarker the drug aims for in melanoma cells — known as PD-L1 — is also present in many cases of the 30 other cancers.

For more details, go to: http://www.heraldsun.com.au/news/drug-that-saved-ron-walker-could-help-wide-range-of-cancer-patients/news-story/0c072c872f2342db23b57f61e582f34d